Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 17689071PMCID PMC2755580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions

  2006cited by this paper
• Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics

  2006cited by this paper
• Human Arsenic Methyltransferase (AS3MT) Pharmacogenetics

  2006cited by this paper
• GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS

  2006cited by this paper
• Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia

  2006cited by this paper
• The International HapMap Project Web site.

  2005cited by this paper
• Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.

  2005cited by this paper
• Human phenylethanolamine N‐methyltransferase pharmacogenomics: gene re‐sequencing and functional genomics

  2005cited by this paper
• Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.

  2005cited by this paper
• Human aromatase: gene resequencing and functional genomics.

  2005cited by this paper
• Beta2-adrenoceptor gene polymorphisms.

  2005cited by this paper
• Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

  2004cited by this paper
• Pharmacogenetics: Inherited Variation in Amino Acid Sequence and Altered Protein Quantity

  2004cited by this paper
• Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation.

  2003cited by this paper
• Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.

  2002cited by this paper
• Score tests for association between traits and haplotypes when linkage phase is ambiguous.

  2002cited by this paper
• Structure/Function Relationships Responsible for the Kinetic Differences between Human Type 1 and Type 2 3β-Hydroxysteroid Dehydrogenase and for the Catalysis of the Type 1 Activity*

  2002cited by this paper
• The engineered, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase: purification, characterization and crystallization.

  2001cited by this paper
• Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.

  2000cited by this paper
• Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.

  1999cited by this paper
• Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.

  1999cited by this paper
• DNA sequence variation in a non-coding region of low recombination on the human X chromosome

  1999cited by this paper
• Creation of a fully active, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase by the deletion of a membrane-spanning domain.

  1999cited by this paper
• Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene: activation by prolactin.

  1999cited by this paper
• Functional activity of 3beta-hydroxysteroid dehydrogenase/isomerase.

  1998cited by this paper
• Consed: a graphical tool for sequence finishing.

  1998cited by this paper
• PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.

  1997cited by this paper
• Synergistic activation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase promoter by the transcription factor steroidogenic factor-1/adrenal 4-binding protein and phorbol ester.

  1997cited by this paper
• Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency.

  1997cited by this paper
• The regulation of 3 beta-hydroxysteroid dehydrogenase expression.

  1997cited by this paper
• Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.

  1996cited by this paper
• Regulation of mammary gland factor/Stat5a during mammary gland development.

  1995cited by this paper
• Characterization of the 3 beta-hydroxysteroid dehydrogenase activity associated with bovine adrenocortical mitochondria.

  1994cited by this paper
• Topology of 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase in adrenal cortex mitochondria and microsomes.

  1994cited by this paper
• Affinity radiolabeling identifies peptides and amino acids associated with substrate binding in human placental 3 beta-hydroxy-delta(5)-steroid dehydrogenase.

  1993cited by this paper
• Dual subcellular localization of the 3 beta-hydroxysteroid dehydrogenase isomerase: characterization of the mitochondrial enzyme in the bovine adrenal cortex.

  1993cited by this paper
• Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.

  1992cited by this paper
• Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity.

  1991cited by this paper
• Congenital Adrenal Hyperplasia in Sweden 1969‐1986 Prevalence, Symptoms and Age at Diagnosis

  1990cited by this paper
• Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.

  1990cited by this paper
• Structural analysis of the gene encoding human 3 beta-hydroxysteroid dehydrogenase/delta 5----4-isomerase.

  1990cited by this paper
• Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.

  1989cited by this paper
• [Congenital adrenal hyperplasia (21-OH) in France. Population genetics].

  1985cited by this paper

• Factors Involved in Prostate Cancer Disparity in African Americans: from Health System to Molecular Mechanisms

  2024cites this paper
• Establishment and characterization of endometrial organoids from different placental types

  2024cites this paper
• Identification of a novel candidate HSD3B2 gene variant for familial hypospadias by whole-exome sequencing

  2023cites this paper
• Transcriptional Reprogramming of Candida tropicalis in Response to Isoespintanol Treatment

  2023cites this paper
• Genetic Testing for a Patient with Suspected 3 Beta-Hydroxysteroid Dehydrogenase Deficiency: A Case of Unreported Genetic Variants

  2022cites this paper
• Improvac induces immunocastration by affecting testosterone levels and disrupting spermatogenesis in male broiler chickens.

  2019cites this paper
• Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer.

  2018cites this paper
• Molecular basis for prostate cancer racial disparities.

  2017cites this paper
• Deficiencia de 3β-hidroxiesteroide deshidrogenasa: una causa rara de hiperplasia adrenal congénita

  2016cites this paper
• Regulation of human (adrenal) androgen biosynthesis-New insights from novel throughput technology studies.

  2016cites this paper
• Two novel HSD3B2 missense mutations with diverse residual enzymatic activities for Δ5‐steroids

  2014cites this paper
• Serum androgen bioactivity is low in children with premature adrenarche

  2014cites this paper
• Albuminuria is associated with too few glomeruli and too much testosterone

  2013cites this paper
• Association of the variations in the HSD3&bgr; gene with primary aldosteronism

  2013cites this paper
• Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

  2013cites this paper
• HSD3B and Gene-Gene Interactions in a Pathway-Based Analysis of Genetic Susceptibility to Bladder Cancer

  2012cites this paper
• Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors

  2012cites this paper
• Udział polimorfizmu genetycznego w biosyntezie estrogenów. Ryzyko nowotworów hormonozależnych

  2011cites this paper
• The proteome of cytosolic lipid droplets isolated from differentiated Caco-2/TC7 enterocytes reveals cell-specific characteristics

  2011cites this paper
• The Effects of Growth Hormone and Insulin-Like Growth Factor-1 Treatments on Hepatic Gene Expression in Obese and Diabetic Mice with Nonalcoholic Fatty Liver Disease

  2010cites this paper
• Gene expression in hypothalamus, liver, and adipose tissues and food intake response to melanocortin-4 receptor agonist in pigs expressing melanocortin-4 receptor mutations.

  2010cites this paper
• Proteasome B Subunit Pharmacogenomics : Gene Resequencing and Functional Genomics

  2008cites this paper
• Proteasome β Subunit Pharmacogenomics: Gene Resequencing and Functional Genomics

  2008cites this paper